N Pavlidis

Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients.

N. Pavlidis, D. Pectasides, D Pectasides, 1996, American journal of clinical oncology.

Cancer of unknown primary site: 20 questions to be answered.

N. Pavlidis, G. Pentheroudakis, N Pavlidis, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

The missing kiss of life: transcriptional activity of the metastasis suppressor gene KiSS1 in early breast cancer.

N. Pavlidis, G. Pentheroudakis, L. Kostadima, 2007, Anticancer research.

Diagnostic and therapeutic management of cancer of an unknown primary.

J. Hainsworth, N. Pavlidis, F. Greco, 2003, European journal of cancer.

The masterclass of the european school of oncology: the 'key educational event' of the school.

F. Cavalli, R. Stahel, N. Pavlidis, 2010, European Journal of Cancer.

Prevention of chemotherapy-induced alopecia using an effective scalp cooling system.

N. Pavlidis, A. Bamias, N Pavlidis, 2000, European journal of cancer.

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.

R. Labianca, J. Berlin, K. Haustermans, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration.

N. Pavlidis, V. Karavasilis, N Pavlidis, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Disseminated intravascular coagulation (DIC) and non-small cell lung cancer (NSCLC): report of a case and review of the literature.

N. Pavlidis, A. Vassou, G. Pentheroudakis, 2009, Lung cancer.